Pharmaceutical Research and Manufacturers of America (PhRMA)

Pharmaceutical Research and Manufacturers of America (PhRMA) website: www.phrma.org

PhRMA "represents the leading research-based pharmaceutical and biotechnology companies in the United States". 

As of November 2004 its members include:

3M, Abbott Laboratories, Amgen, AstraZeneca, Aventis, Bayer, Berlex (part of Schering AG), Biogen Idec, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Pharmaceutical, Eli Lilly, Fujisawa Healthcare, GE Healthcare (part of General Electric), Genzyme, GlaxoSmithKline, Hoffmann-La Roche, Johnson & Johnson, Merck, Millennium Pharmaceuticals, Procter & Gamble, Novartis, Organon, Otsuka, Pfizer, Purdue Pharma, Sanofi-Aventis, Savient, Schering-Plough, Schwarz Pharma, Sepracor, Serono, Solvay, Valeant, Wyeth

Its affiliates and associates include:

aaiPharma, Accenture, Alkermes, Altana Pharma, Amylin, Automsoft, Boston Consulting Group, Celgene, Cephalon, CommonHealth, Compugen, Corus Pharma, Dendrite International, Eisai, Enzon, Ernst & Young, Euro RSCG Life, Eyetech Pharmaceuticals, FCB Healthcare, HealthSTAR Communications, ICOS, Idenix, IMS Health, Isis Pharmaceuticals, J. Scott International, KPMG, Maxim Pharmaceuticals, McGraw-Hill, McKesson, Medi-Promotions, Medicus Group, MediMedia, MGI Pharma, Nelson Communications, NOP World Health, Novo Nordisk, PDI, Penwest Pharmaceuticals, Quintiles Transnational, Saatchi, Sankyo Pharma, Sigma-Tau Pharmaceuticals, Stressgen Biotechnologies, Takeda Pharmaceuticals, TargetRx, Theravance, Thomson Healthcare, Vela Pharmaceuticals, Ventiv Health, Yamanouchi Pharma

PhRMA's current full list of members.

Get RSS feed of these results

Related stories and components

Article
31 December 2004

[PDF] Business and Economic Development: Pharmaceutical Sector Report

Author: AccountAbility & Business for Social Responsibility

[refers to Merck, Novo Nordisk, Aspen Pharmacare, Grunenthal, Novartis, Citadel Aurobindo Biotech & Citadel Fine Pharmaceuticals (both part of Aurobindo Pharmaceuticals), Abbott Laboratories, Bristol Myers-Squibb, Pfizer, Schering-Plough, Eli Lilly...

Read more

Article
1 October 2004

[PDF] Sector profile of the pharmaceutical industry

Author: Francis Weyzig, SOMO (Centre for research on Multinational Corporations)

[Report provides overview of pharmaceutical sector, examines issues such as: Access to medicines; clinical trials; drug safety; drug promotion & advertising; indigenous knowledge; workplace health, safety, environment; employment conditions.] ...

Read more

Article
26 August 2003

Pharmaceutical Research and Manufacturers of America [PhRMA] website

Read more

Article
15 November 2001

WTO: Agreement Reached In Doha; January Trade Round Set

Author: UN Wire

...Even in light of the agreement allowing developing countries to break patents in the name of public health, the optimism of drug companies has not been dampened, the Wall Street Journal reports. "This does not change the way we sell our medicines,"...

Read more

  • Related companies: Merck
Article
24 October 2001

Global Partnerships: Humanitarian Programs of the Pharmaceutical Industry in Developing Nations

Author: PhRMA [Pharmaceutical Research and Manufacturers of America]

Typically working in partnership with local non-governmental organizations (NGOs), as well as international health and relief organizations, pharmaceutical companies are directly involved in improving public health...From 1998 through 2001, the...

Read more

Article
16 October 2001

Comment on the Attaran/Gillespie-White and PhRMA surveys of patents on Antiretroviral drugs in Africa

Author: Consumer Project on Technology, Essential Action, Oxfam, Treatment Access Campaign & Health Gap

The following is a comment on two reports being circulated by the pharmaceutical industry regarding the importance of patents in Africa as a barrier to treatment for AIDS...The assertion in both documents is that patents are not an important barrier...

Read more

Article
30 September 2001

Facts and Figures on Patenting and Access in Africa

Author: PhRMA [Pharmaceutical Research and Manufacturers of America]

Read more

Story
30 September 2001

Patents Do Matter in Africa According to NGOs

See full story

Article
10 September 2001

Medical Journals Set New Publication Rules

Author: Susan Okie, Washington Post

About 12 of the world's most prominent medical journals are issuing a joint editorial this week stating that they will reject any scientific studies that do not come with an assurance that the sponsor -- whether a drug company or other organization --...

Read more

Article
11 August 2001

[PDF] "Pharmaceutical Industry R&D Costs: Key Findings about the Public Citizen Report," An Ernst and Young Study

Author: Pharmaceutical Research and Manufacturers of America [PhRMA]

Read more